The DOI matches its Crossref record; 31 of the 31 references it cites were found in a registry or an index.
Nicotinamide phosphoribosyltransferase protects against ischemic stroke through SIRT1‐dependent adenosine monophosphate–activated kinase pathway
Abstract
Objective: Stroke is a leading cause of mortality and disability. Nicotinamide phosphoribosyltransferase (Nampt) is the rate‐limiting enzyme in mammalian nicotinamide adenine dinucleotide (NAD)+ biosynthesis and contributes to cell fate decisions. However, the role of Nampt in brain and stroke remains to be investigated. Methods: We used lentivirus‐mediated Nampt overexpression and knockdown to manipulate Nampt expression and explore the effects of Nampt in neuronal survival on ischemic stress both in vivo and in vitro. We also used adenosine monophosphate (AMP)‐activated kinase‐α2 (AMPKα2) and silent mating type information regulation 2 homolog 1 (SIRT1) knockout mice to investigate the underlying mechanisms of Nampt neuroprotection. Results: Nampt inhibition by a highly‐specific Nampt inhibitor, FK866, aggravated brain infarction in experimentally cerebral ischemia rats, whereas Nampt overexpression in local brain and Nampt enzymatic product nicotinamide mononucleotide (NMN) reduced ischemia‐induced cerebral injuries. Nampt overexpression and knockdown regulated neuron survival via the AMPK pathway. Neuroprotection of Nampt was abolished in AMPKα2−/− neurons. In neurons, Nampt positively modulated NAD+ levels and thereby controlled SIRT1 activity. SIRT1 coprecipitated with serine/threonine kinase 11 (LKB1), an upstream kinase of AMPK, and promoted LKB1 deacetylation in neurons. Nampt‐induced LKB1 deacetylation and AMPK activation disappeared in SIRT1−/− neurons. In contrast, Ca 2+/calmodulin‐dependent protein kinase kinase‐β (CaMKK‐β), another upstream kinase of AMPK, was not involved in the neuroprotection of Nampt. More important, Nampt overexpression‐induced neuroprotection was abolished in SIRT1+/− and AMPKα2−/− mice. Interpretation: Our findings reveal that Nampt protects against ischemic stroke through rescuing neurons from death via the SIRT1‐dependent AMPK pathway and indicate that Nampt is a new therapeutic target for stroke. Ann Neurol 2011.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
AMPK regulates energy expenditure by modulating NAD+ metabolism and SIRT1 activity
Cantó, C., Gerhart-Hines, Z., Feige, J. N., Lagouge, M., Noriega, L., Milne, J. C., Elliott, P. J., Puigserver, P., & Auwerx, J. (2009) · Nature · doi:10.1038/nature07813 · Cited by 3,300
Donnan, G. A., Fisher, M., Macleod, M., & Davis, S. M. (2008) · The Lancet · doi:10.1016/s0140-6736(08)60694-7 · Cited by 2,218
AMP-activated/SNF1 protein kinases: conserved guardians of cellular energy
Hardie, D. G. (2007) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm2249 · Cited by 2,216
Mechanisms, challenges and opportunities in stroke
Lo, E. H., Dalkara, T., & Moskowitz, M. A. (2003) · Nature Reviews Neuroscience · doi:10.1038/nrn1106 · Cited by 1,781
Revollo, J. R., Grimm, A. A., & Imai, S.-I. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.m408388200 · Cited by 1,010
Nutrient-Sensitive Mitochondrial NAD+ Levels Dictate Cell Survival
Yang, H., Yang, T., Baur, J. A., Perez, E., Matsui, T., Carmona, J. J., Lamming, D. W., Souza-Pinto, N. C., Bohr, V. A., Rosenzweig, A., et al. (2007) · Cell · doi:10.1016/j.cell.2007.07.035 · Cited by 950
Nampt/PBEF/Visfatin Regulates Insulin Secretion in β Cells as a Systemic NAD Biosynthetic Enzyme
Revollo, J. R., Körner, A., Mills, K. F., Satoh, A., Wang, T., Garten, A., Dasgupta, B., Sasaki, Y., Wolberger, C., Townsend, R. R., et al. (2007) · Cell Metabolism · doi:10.1016/j.cmet.2007.09.003 · Cited by 911
SIRT1 Modulation of the Acetylation Status, Cytosolic Localization, and Activity of LKB1
Lan, F., Cacicedo, J. M., Ruderman, N., & Ido, Y. (2008) · Journal of Biological Chemistry · doi:10.1074/jbc.m805711200 · Cited by 825
Fulco, M., Cen, Y., Zhao, P., Hoffman, E. P., McBurney, M. W., Sauve, A. A., & Sartorelli, V. (2008) · Developmental Cell · doi:10.1016/j.devcel.2008.02.004 · Cited by 820
The Mammalian SIR2α Protein Has a Role in Embryogenesis and Gametogenesis
McBurney, M. W., Yang, X., Jardine, K., Hixon, M., Boekelheide, K., Webb, J. R., Lansdorp, P. M., & Lemieux, M. (2003) · Molecular and Cellular Biology · doi:10.1128/mcb.23.1.38-54.2003 · Cited by 611
Rongvaux, A., Shea, R. J., Mulks, M. H., Gigot, D., Urbain, J., Leo, O., & Andris, F. (2002) · European Journal of Immunology · doi:10.1002/1521-4141(200211)32:11<3225::aid-immu3225>3.0.co;2-l · Cited by 548
The AMP-activated protein kinase α2 catalytic subunit controls whole-body insulin sensitivity
Viollet, B., Andreelli, F., Jørgensen, S. B., Perrin, C., Geloen, A., Flamez, D., Mu, J., Lenzner, C., Baud, O., Bennoun, M., et al. (2003) · Journal of Clinical Investigation · doi:10.1172/jci16567 · Cited by 499
Self-citationAvalos, J. L., Bever, K. M., & Wolberger, C. (2005) · Molecular Cell · doi:10.1016/j.molcel.2005.02.022 · Cited by 464
NAD + Depletion Is Necessary and Sufficient forPoly(ADP-Ribose) Polymerase-1-Mediated Neuronal Death
Alano, C. C., Garnier, P., Ying, W., Higashi, Y., Kauppinen, T. M., & Swanson, R. A. (2010) · The Journal of Neuroscience · doi:10.1523/jneurosci.5552-09.2010 · Cited by 439 · cited 2×
“It has been reported that NADþ depletion is necessary and sufficient for PARP-1-mediated neuronal death.(26) Therefore supplementation of NADþ is neuroprotective and prevents PARP-1-mediated cell death in vitro.”
BackgroundAdya, R., Tan, B. K., Punn, A., Chen, J., & Randeva, H. S. (2008) · Cardiovascular Research · doi:10.1093/cvr/cvm111 · Cited by 437
Pillai, J. B., Isbatan, A., Imai, S.-I., & Gupta, M. P. (2005) · Journal of Biological Chemistry · doi:10.1074/jbc.m506162200 · Cited by 391
Extension of Human Cell Lifespan by Nicotinamide Phosphoribosyltransferase
van der Veer, E., Ho, C., O'Neil, C., Barbosa, N., Scott, R., Cregan, S. P., & Pickering, J. G. (2007) · Journal of Biological Chemistry · doi:10.1074/jbc.c700018200 · Cited by 325
Wang, P., Xu, T.-Y., Guan, Y.-F., Su, D.-F., Fan, G.-R., & Miao, C.-Y. (2009) · Cardiovascular Research · doi:10.1093/cvr/cvn288 · Cited by 304
Self-citationTurnley, A. M., Stapleton, D., Mann, R. J., Witters, L. A., Kemp, B. E., & Bartlett, P. F. (1999) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.1999.721707.x · Cited by 262
Postischemic treatment of neonatal cerebral ischemia should target autophagy
Puyal, J., Vaslin, A., Mottier, V., & Clarke, P. G. H. (2009) · Annals of Neurology · doi:10.1002/ana.21714 · Cited by 259
Li, Y., Zhang, Y., Dorweiler, B., Cui, D., Wang, T., Woo, C. W., Brunkan, C. S., Wolberger, C., Imai, S.-I., & Tabas, I. (2008) · Journal of Biological Chemistry · doi:10.1074/jbc.m805866200 · Cited by 211
ORP150 protects against hypoxia/ischemia-induced neuronal death
Tamatani, M., Matsuyama, T., Yamaguchi, A., Mitsuda, N., Tsukamoto, Y., Taniguchi, M., Che, Y. H., Ozawa, K., Hori, O., Nishimura, H., et al. (2001) · Nature Medicine · doi:10.1038/85463 · Cited by 197
van der Veer, E., Nong, Z., O’Neil, C., Urquhart, B., Freeman, D., & Pickering, J. G. (2005) · Circulation Research · doi:10.1161/01.res.0000173298.38808.27 · Cited by 187
Estimated 10‐year stroke risk by region and race in the United States
Cushman, M., Cantrell, R. A., McClure, L. A., Howard, G., Prineas, R. J., Moy, C. S., Temple, E. M., & Howard, V. J. (2008) · Annals of Neurology · doi:10.1002/ana.21493 · Cited by 124
Recombinant C1 inhibitor in brain ischemic injury
Gesuete, R., Storini, C., Fantin, A., Stravalaci, M., Zanier, E. R., Orsini, F., Vietsch, H., Mannesse, M. L. M., Ziere, B., Gobbi, M., et al. (2009) · Annals of Neurology · doi:10.1002/ana.21740 · Cited by 120
Wang, S., Xing, Z., Vosler, P. S., Yin, H., Li, W., Zhang, F., Signore, A. P., Stetler, R. A., Gao, Y., & Chen, J. (2008) · Stroke · doi:10.1161/strokeaha.107.509158 · Cited by 118
Muruganandham, M., Alfieri, A. A., Matei, C., Chen, Y., Sukenick, G. D., Schemainda, I., Hasmann, M., Saltz, L. B., & Koutcher, J. A. (2005) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-04-1399 · Cited by 98
Delayed treatment with a p53 inhibitor enhances recovery in stroke brain
Luo, Y., Kuo, C., Shen, H., Chou, J., Greig, N. H., Hoffer, B. J., & Wang, Y. (2009) · Annals of Neurology · doi:10.1002/ana.21592 · Cited by 94
Selective vulnerability in Alzheimer's disease: Amyloid precursor protein and p75NTR interaction
Fombonne, J., Rabizadeh, S., Banwait, S., Mehlen, P., & Bredesen, D. E. (2009) · Annals of Neurology · doi:10.1002/ana.21578 · Cited by 72
Excitotoxicity‐induced endocytosis confers drug targeting in cerebral ischemia
Vaslin, A., Puyal, J., & Clarke, P. G. H. (2009) · Annals of Neurology · doi:10.1002/ana.21584 · Cited by 30
Vinet, J., Carra, S., Blom, J. M. C., Harvey, M., Brunello, N., Barden, N., & Tascedda, F. (2003) · Molecular Brain Research · doi:10.1016/s0169-328x(02)00698-8 · Cited by 24
Cited by
Pharmacological modulation of autophagy: therapeutic potential and persisting obstacles
Galluzzi, L., Bravo-San Pedro, J. M., Levine, B., Green, D. R., & Kroemer, G. (2017) · Nature Reviews Drug Discovery · doi:10.1038/nrd.2017.22 · Cited by 842
Mechanisms of neuronal cell death in ischemic stroke and their therapeutic implications
Tuo, Q., Zhang, S., & Lei, P. (2022) · Medicinal Research Reviews · doi:10.1002/med.21817 · Cited by 728
Hasegawa, K., Wakino, S., Simic, P., Sakamaki, Y., Minakuchi, H., Fujimura, K., Hosoya, K., Komatsu, M., Kaneko, Y., Kanda, T., et al. (2013) · Nature Medicine · doi:10.1038/nm.3363 · Cited by 483
Sirtuins, a promising target in slowing down the ageing process
Grabowska, W., Sikora, E., & Bielak-Zmijewska, A. (2017) · Biogerontology · doi:10.1007/s10522-017-9685-9 · Cited by 470
Li, X. (2013) · Acta Biochimica et Biophysica Sinica · doi:10.1093/abbs/gms108 · Cited by 360
Metadata
- Authors
- Wang, P., Xu, T., Guan, Y., Tian, W., Viollet, B., Rui, Y., Zhai, Q., Su, D., & Miao, C.
- Venue
- Annals of Neurology
- Publisher
- Wiley
- Published
- 2011-01-19
- Volume
- 69
- Issue
- 2
- Pages
- 360-374
- ISSN
- 0364-5134 (ISSN-L)
- 1531-8249
- OpenAlex
- W2129061491
- Cited by
- 288
- References
- 31
- FWCI
- 12.75
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.